Sugi Predict

Sugi Predict / Compounds / SCHEMBL224256

SCHEMBL224256

SCHEMBL224256

C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@H](O)C2=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 8/20 0.72
▸ ESR1 P03372 7/20 0.69
▸ ESR2 Q92731 5/20 0.69
▸ LMNA P02545 4/20 0.69
▸ SHBG P04278 4/20 0.69
▸ HSD17B10 Q99714 4/20 0.69
▸ PGR P06401 3/20 0.69
▸ SERPINA6 P08185 3/20 0.69
▸ AR P10275 3/20 0.69
▸ SLC6A4 P31645 3/20 0.69
▸ SNCA P37840 3/20 0.69
▸ SLC6A3 Q01959 3/20 0.69
▸ HIF1A Q16665 3/20 0.69
▸ AKR1B10 O60218 2/20 0.69
▸ CYP1A2 P05177 2/20 0.69
▸ CYP3A4 P08684 2/20 0.69
▸ STS P08842 2/20 0.69
▸ MAPT P10636 2/20 0.69
▸ AKR1B1 P15121 2/20 0.69
▸ HTR2B P41595 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29834891 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL30489998 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL11861252 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL2310466 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL13123066 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL23711105 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL13123064 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL193937 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL21631888 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG
SCHEMBL29382203 1.00 HSD17B1 (0.72) HSD17B1ESR1ESR2LMNASHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212532-A1 P450 BM3 MONOOXYGENASE VARIANTS FOR C19-HYDROXYLATION OF STEROIDS BAYER AKTIENGESELLSCHAFT (DE) 2023-07-06 — — US disclosed
US-20230212532-A1 P450 BM3 MONOOXYGENASE VARIANTS FOR C19-HYDROXYLATION OF STEROIDS BAYER AKTIENGESELLSCHAFT (DE) 2023-07-06 — — US disclosed
EP-4100515-A1 P450 BM3 MONOOXYGENASE VARIANTS FOR C19-HYDROXYLATION OF STEROIDS Bayer Aktiengesellschaft (DE) 2022-12-14 — — EP disclosed
US-20220204448-A1 CRYSTALLINE FORMS AND METHODS OF PRODUCING CRYSTALLINE FORMS OF A COMPOUND LIGAND PHARMACEUTICALS INC. 2022-06-30 — — US disclosed
US-11358931-B2 Selective androgen receptor modulators (SARMs) and uses thereof LIGAND PHARMACEUTICALS INCORPORATED (US) 2022-06-14 — — US disclosed
WO-2021156200-A1 P450 BM3 MONOOXYGENASE VARIANTS FOR C19-HYDROXYLATION OF STEROIDS BAYER AKTIENGESELLSCHAFT (DE) 2021-08-12 — — WO disclosed
EP-3858986-A1 P450 BM3 MONOOXYGENASE VARIANTS FOR C19-HYDROXYLATION OF STEROIDS Bayer Aktiengesellschaft (DE) 2021-08-04 — — EP disclosed
US-10874638-B2 Methods and compositions for modulating hormone levels LIGAND PHARMACEUTICALS INCORPORATED (US) 2020-12-29 — — US disclosed
US-20200361866-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2020-11-19 — — US disclosed
US-10730831-B2 Selective androgen receptor modulators (SARMs) and uses thereof LIGAND PHARMACEUTICALS INCORPORATED (US) 2020-08-04 — — US disclosed
WO-2009082437-A9 SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF LIGAND PHARMACEUTICALS INCORPORATED (US) 2010-08-12 — — WO disclosed
WO-2009082437-A2 SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-07-02 — — WO disclosed
WO-2007103638-A2 HORMONE REPLACEMENT FORMULATION WRIGHT JONATHAN V (US) 2007-09-13 — — WO disclosed
US-20070212427-A1 Hormone replacement formulation WRIGHT JONATHAN V 2007-09-13 — — US disclosed
US-6911438-B2 Hormone replacement formulation WRIGHT JONATHAN V (US) 2005-06-28 — — US disclosed
EP-0475160-B2 Preparation for drug application in minute droplet form IDEA AG (DE) 2004-07-14 — — EP disclosed
US-20030050287-A1 Hormone replacement formulation WRIGHT JONATHAN V (US) 2003-03-13 — — US disclosed
EP-0475160-B1 Preparation for drug application in minute droplet form IDEA AG (DE) 1996-02-14 — — EP disclosed
EP-0475160-A1 Preparation for drug application in minute droplet form Cevc, Gregor, Prof. Dr. (DE) 1992-03-18 — — EP disclosed
WO-1992003122-A1 PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS CEVC GREGOR (DE) 1992-03-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204448-A1 CRYSTALLINE FORMS AND METHODS OF PRODUCING CRYSTALLINE FORMS OF A COMPOUND RCC1, CYP2F1, CENPE HSD17B1 223/4885ESR1 4562/4885ESR2 2726/4885
US-20200361866-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF AR, NR5A1, SHBG HSD17B1 57/4885ESR1 29/4885ESR2 21/4885
US-11358931-B2 Selective androgen receptor modulators (SARMs) and uses thereof AR, NR5A1, SHBG HSD17B1 41/4885ESR1 34/4885ESR2 17/4885
US-10874638-B2 Methods and compositions for modulating hormone levels SHBG, ESRRB, ESRRA HSD17B1 36/4885ESR1 9/4885ESR2 6/4885
US-10730831-B2 Selective androgen receptor modulators (SARMs) and uses thereof AR, NR5A1, SHBG HSD17B1 41/4885ESR1 34/4885ESR2 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.